Cargando…
Wee1-Hsp90 inhibitor combination treatment: Molecular therapy with potentially broad applicability
Autor principal: | Lokeshwar, Vinata B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495812/ https://www.ncbi.nlm.nih.gov/pubmed/22983000 http://dx.doi.org/10.4161/cc.22119 |
Ejemplares similares
-
Predicting PARP inhibitor sensitivity and resistance
por: Bebb, D. Gwyn, et al.
Publicado: (2012) -
Neighborhood matters: Response to EZH2 methyltransferase inhibitors
por: Gharpure, Kshipra M, et al.
Publicado: (2013) -
HDAC inhibitors repress the polycomb protein BMI1
por: Grant, Steven
Publicado: (2010) -
Addicted to PAR?: A closer look at PARP inhibitor sensitivity
por: Altmeyer, Matthias
Publicado: (2012) -
Unfolding tyrosine kinase inhibitor sensitivity in chronic myeloid leukemia
por: Perrotti, Danilo, et al.
Publicado: (2012)